Scott T. Rottinghaus, Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 21,619 shares at $15.07 ($347K) on 2024-07-11, disclosed to the SEC on 2024-07-15.
Scheduled sale ($347k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.07 | 4,299 | $65K | 18.7% |
| 2 | $15.07 | 4,299 | $65K | 18.7% |
| 3 | $15.04 | 2,271 | $34K | 9.8% |
| 4 | $17.08 | 5,375 | $92K | 26.4% |
| 5 | $17.08 | 5,375 | $92K | 26.4% |
| Total | $16.07 avg | 21,619 |
| $347K |
| 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $5K | — | Filing → |